Navigation Links
New NIAID grants strengthen national biodefense and emerging infectious diseases research network

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four-year grants totaling approximately $80 million for two new Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE). The grants to the University of California, Irvine, and Colorado State University (Fort Collins) mark the completion of a national network of academic centers that conducts research to counter threats from bioterror agents and emerging infectious diseases. Each institution will receive approximately $10 million per year for the next four years to head a regional research consortium. The RCE network was identified as a national priority in the 2002 NIAID Biodefense Research Agenda.

"Since before the 2001 anthrax attacks, the United States has been at risk for a bioterror attack. With these grants, a key element of our strategic plan to counter bioterrorism and emerging infectious diseases is now complete," says Anthony S. Fauci, M.D., director of NIAID. "Our network is working diligently to uncover new knowledge and create preventive, therapeutic and diagnostic tools that will leave us far less vulnerable."

NIAID established the RCE network in 2003 with grants to eight institutions. Each institution also leads an RCE consortium made up of universities and other research institutions within its geographic region. The network conducts research that will lead to next-generation treatments, vaccines and diagnostic tools for diseases such as anthrax, plague, smallpox, tularemia, botulism and West Nile fever.

University of California, Irvine, principal investigator Alan G. Barbour, M.D., will head a consortium whose members include four additional University of California campuses and 11 other regional universities and research institutions.

Colorado State University principal investigator Barry J. Beaty, Ph.D., will head a consortium whose members include five o ther universities plus small business partners; it also includes substantial collaboration with the Centers for Disease Control and Prevention.

The addition of these two new RCEs expands the network's scientific reach to cover some poorly understood diseases and new research needs. For example, researchers in the new centers have expertise in equine encephalitis and other viral diseases that can be transmitted to people by mosquitoes. The centers also add expertise in hantaviruses, as well as in the development of diagnostics and animal models of disease.

Each consortium within the network will

* support investigator-directed research
* train researchers and other personnel for biodefense research activities
* create and maintain supporting resources, including scientific equipment and trained support personnel, for use by other researchers within in the region and network
* emphasize research focused on development and testing of vaccines, therapeutic and diagnostic concepts
* make available core facilities to approved investigators from academia, government, biotech companies and the pharmaceutical industry
* provide facilities and scientific support to first responders in the event of a national biodefense emergency

The previously established RCEs in the network are led by Duke University, Harvard Medical School, New York State Department of Health, University of Chicago, University of Maryland, University of Texas Medical Branch (Galveston), University of Washington and Washington University in St. Louis. Additional information on NIAID's biodefense program is available online at http://www.niaid.nih.gov/Biodefense/Research/rce.htm.


'"/>

Source:NIH


Related biology news :

1. NIAID Initiates Trial of Experimental Avian Flu Vaccine
2. NIAID begins clinical trial of West Nile virus vaccine
3. NIAID researchers show how promising TB drug works
4. NIAID DNA vaccine for H5N1 avian influenza enters human trial
5. NIAID expands capability for influenza research and surveillance
6. Asian immigrants in NYC not receiving HIV education at religious institutions
7. Scientists win grants to develop $1,000 genome sequencing technology
8. UCLA scientists strengthen case for life more than 3.8 billion years ago
9. Brain networks strengthened by closing ion channels
10. International trial of two microbicides begins
11. International HapMap consortium expands mapping effort
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., a ... simplifies the use and access of ubiquitous on-premise ... partnership with American Cyber.  ... experience leading transformational C4ISR and Cyber initiatives in ... the latest proven technology solutions," said Steve ...
(Date:1/11/2016)...  higi, the leading retail and omni-channel community engagement ... and mobile, today announced it has closed funding ... --> --> ... higi,s health platform – its network of health ... expanding services and programs to retail partners and ...
(Date:1/7/2016)... 2016  A United States District Court in ... the country to interpret a biometric privacy statute in ... against the photo website Shutterfly brought by the law firm ... vs. SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. ... violates the Illinois Biometric Privacy Act by collecting and ...
Breaking Biology News(10 mins):
(Date:2/6/2016)... ... February 06, 2016 , ... ... The Center for Excellence in Education Sponsors Teacher Training Program , Bite of ... 2016 – The Center for Excellence in Education (CEE) will sponsor a Bite ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... that Edward Lanphier , Sangamo,s president and chief ... of Sangamo,s ZFP Therapeutic ® development programs and ... pm ET on Thursday, February 11, 2016, at the ... The conference is being held in New ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
Breaking Biology Technology: